Brind.

Charles Schoch, who holds an MBA and MSA from Northeastern University, served as Corporate Controller at Corbus Pharmaceuticals and was appointed CFO of Candel Therapeutics.

1 report, 0 independent Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Charles Schoch, who holds an MBA and MSA from Northeastern University, served as Corporate Controller at Corbus Pharmaceuticals and was appointed CFO of Candel Therapeutics.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet